Lanthio Pharma
Latest round
- Series A
Last raised
- Nov 2012
Total raised
- $6.2M
Investors
- 3
About Lanthio Pharma
Based in Netherlands, Lanthio Pharma is a biopharmaceutical company focused on discovering and developing Lantipeptides, a new class of peptides with high target selectivity and improved "drug-like" properties.
Who invested in Lanthio Pharma
3 investors across 1 round
See all investors in Lanthio Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 27, 2012
Amount
$6.2M
Investors
Questions about Lanthio Pharma
Who invested in Lanthio Pharma?
Lanthio Pharma has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lanthio Pharma raised?
Lanthio Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lanthio Pharma last raise money?
Lanthio Pharma's most recent round on record is a Series A, in Nov 2012.
What does Lanthio Pharma do?
Based in Netherlands, Lanthio Pharma is a biopharmaceutical company focused on discovering and developing Lantipeptides, a new class of peptides with high target selectivity and improved "drug-like" properties.
Where is Lanthio Pharma headquartered?
Lanthio Pharma is headquartered in Groningen, Netherlands.
Which VCs invest in companies like Lanthio Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Lanthio Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Lanthio Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.